ArticleApplied health economics and health policy2026
Spillover Effects of Medical Innovations: A Universal and Scalable Approach to Measure the Societal Value of Avoided Informal Care Time.
Article in Applied health economics and health policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveInformal caregiving is essential to comprehensive patient care, yet sustained caregiving can lower caregivers' quality of life and productivity, with implications for labor supply and economic growth. Most studies quantify caregiver burden without linking it to patients' utility, obscuring how health gains translate into caregiving demand. We extend a published framework for valuing the social impact of medical interventions by incorporating informal caregiving as a scalable dimension of societal value, enabling estimation of caregiver productivity effects where direct caregiver data are unavailable.
methodsWe established a generic relationship between patients' quality-adjusted life-years (QALYs) and caregiving time by leveraging published correlations between EQ-5D and daily care time. Incremental QALYs were converted into age- and ICD10 chapter-specific hourly reductions in caregiving time. To address the "QALY-trap," we established a QALY-composition approximation. Using nationally representative time-use data, we estimated how freed time is reallocated to paid work, unpaid work, and leisure, and we quantified the socioeconomic value of avoided informal care time as opportunity costs, including direct effects on paid and unpaid work and broader impacts.
resultsWe demonstrated use in a case study of relapsing-remitting multiple sclerosis treated with ofatumumab across five countries. Ofatumumab reduced informal caregiving between 17.34 and 18.38 h per treated patient-year. In Germany, caregiver productivity gains were $468 per patient-year and represented about 7.2% of the patient productivity component of total social impact. Findings were directionally similar across settings.
conclusionsThe method incorporates the caregiver perspective into economic evaluations by linking patient utility gains to changes in caregiving demand and their societal consequences. The framework provides a transparent and transferable approximation for estimating caregiver productivity spillovers when direct caregiver data are unavailable.
Identifiers
42758459What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.